Diagnostic Validation of PERC and Resource Utilization in Suspected Acute Pulmonary Embolism: A Systematic Review and Meta-Analysis
Abstract
Background and AimsPulmonary embolism (PE) is a frequent and potentially fatal diagnosis in the emergency department (ED). The Pulmonary Embolism Rule-out Criteria (PERC), an eight-item clinical decision rule used to identify patients at very low risk of pulmonary embolism, is widely applied to exclude PE in low-risk patients; however, its real-world diagnostic performance and impact on imaging utilization remain incompletely defined. This systematic review aimed to evaluate the diagnostic accuracy of PERC and its effect on reducing computed tomography pulmonary angiography (CTPA) use.Materials and MethodsThis review followed the Joanna Briggs Institute (JBI) methodology for diagnostic test accuracy studies. Eligible studies enrolled ED patients with suspected PE who were classified as low risk according to the original study-specific approaches, including clinician gestalt, Wells score, revised Geneva score, or YEARS-based assessment. PubMed, Web of Science Core Collection, the Cochrane Library, and ClinicalTrials.gov were searched for eligible studies published between 2004 and 2025.ResultsTen studies involving 13,672 patients were included. The pooled PE prevalence was 7%. The pooled sensitivity, specificity, and negative predictive value of PERC were 95% (95% CI: 89%-98%), 26% (95% CI: 16%-40%), and 98.2% (95% CI: 97.8%-99.0%), respectively. PERC application was associated with a significant reduction in imaging utilization (RR = 0.85, 95% CI: 0.80-0.91).ConclusionsPERC…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 13,672 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.